Skip to main content

Table 1 Baseline characteristics of the 48 patients

From: Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial

Characteristics Rifampin group (n = 23) Monotherapy group (n = 25) Total (n = 48)
Age, year, median (range) 70 (37–92) 66 (39–84) 68.5 (37–92)
Sex, male (%) 15 (65) 17 (68) 32 (67)
ASA scores 1–2, no (%) 16 (70) 21 (84) 37 (77)
BMI, mean (SD) 30.1 (1.3) 27 (1.0) 28.4 (0.8)
Diabetes mellitus 3 3 6
Immunosuppressive medication 2 2 4
Smoking 3 4 7
Time from index surgery to revision, median, days (range) 19 (7–912) 17 (8–122) 18 (7–912)
Hip prosthesis
 Primary hip prosthesis 17 14 31
 Revision hip prostehesis 3 5 8
Knee prosthesis
 Primary knee prosthesis 3 6 9
CRP pre surgery, mean (SD) 135 (21.1) 167 (26.4) 151 (16.9)
Creatinin pre surgery, mean (SD) 78 (5.7) 79 (4.4) 79 (3.5)
Type of prosthesisa
 Cemented prosthesis 14 16 30
 Non cemented 4 5 9
 Reverse hybrid 4 4 8
  1. ASA American Society of Anesthesiologists physical status classifications system, BMI body mass index
  2. aMissing data, n = 1